[Myocardial disease in viral infections. Myocarditis--cardiomyopathy].
Inflammation of the myocardium is a common cardiac disease. Molecular and immunhistological techniques help to assure myocarditis in terms of persistence of chronic viral infection and myocardial inflammation activity. The connection between viral myocarditis and development of dilative cardiomyopathy is of great interest. Thus, new possibilities arise for assessment of the disease prognosis and the strategy of specific immunosuppressive, immunomodulating and antiviral therapy.
Brehm
Michael
M
Medizinische Klinik B, Klinik für Kardiologie, Pneumologie und Angiologie, Heinrich-Heine-Universität Düsseldorf. Brehm@med.uni-duesseldorf.de
D000998:Antiviral Agents / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D002908:Chronic Disease; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009205:Myocarditis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D011379:Prognosis; D014777:Virus Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
D000998:Antiviral Agents; D007155:Immunologic Factors; D007166:Immunosuppressive Agents